CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | Swain Judith L Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | Palantoni Frank Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | Palantoni Frank Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | LEFKOWITZ ROBERT J MD Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | LEFKOWITZ ROBERT J MD Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | NIES ALAN S Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | NIES ALAN S Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | DEBBANE RAYMOND Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | DEBBANE RAYMOND Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | BARKER SAM L Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | BARKER SAM L Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-30 | Amouyal Philippe Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | Amouyal Philippe Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 | ||
| 2021-04-24 | Swain Judith L Director | Exercise or conversion | +10,638 | 27,006 | ||
| 2021-04-24 | Swain Judith L Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | SOBECKI CHRISTOPHER J Director | Exercise or conversion | +10,638 | 151,397 | ||
| 2021-04-24 | SOBECKI CHRISTOPHER J Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | Palantoni Frank Director | Exercise or conversion | +10,638 | 27,006 | ||
| 2021-04-24 | Palantoni Frank Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 |
Page 27 of 27 · 540 trades